ISPOR Europe 2018 concluded yesterday in Barcelona, Spain with record attendance. The Society had 5507 total attendees register for the event—the largest for any of its conferences to date.
Patients with centralized pain (fibromyalgia-like phenotype) are less likely to respond to a type of facet joint pain treatment called radiofrequency ablation (RFA), according to the results of a study from researchers at the University of Michigan in Ann Arbor, MI.
Patients with fibromyalgia who use tobacco products are at greater risk for cognitive impairment and other symptoms that affect quality of life, according to the results of a study from the Mayo Clinic in Rochester, MI.
A higher polygenic risk score—a genetic analysis computed from a combination of several of a person’s genes—is associated with more frequent and severe headaches. The findings support the idea that a propensity for headaches has a genetic basis.
A minimal opiate supply, just a two-day course compared to a traditional two-week prescription, along with a scheduled-dose multimodal pain regimen after surgery limits the use of opiate medication by patients and, subsequently, opiate-related adverse effects while still providing effective pain control and high patient satisfaction.
Adding steroids to local anesthetic increases the success rate of short-term but not long-term relief of chronic non-cancer pain.
Physician education and training about LGBTQ medical needs are much needed to improve their attitudes and skills in treating LGBTQ patients and increase patients’ satisfaction with their medical care.
44 percent of people who died from fentanyl overdose had previously been prescribed fentanyl by a medical professional, and 37 percent of those people had a prescription for fentanyl within 60 days of their death.
ISPOR Europe 2018 session addresses challenges to open science, including data sharing, replication, and robustness of evidence from real-world data.
A Phase I/II study, led by investigators at The University of Texas MD Anderson Cancer Center, reports an investigational drug called tagraxofusp has demonstrated high response rates in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare but highly aggressive – and often fatal bone marrow and blood disorder – for which there are no existing approved therapies.
The third plenary of ISPOR Europe 2018 focused on the issue of budget impact and expenditure caps in healthcare.
Previously incarcerated transgender women can find themselves caught in a cycle that leads to repeat jail time. A new analysis identifies potential solutions that could lead to transgender women being more successfully reintegrated into society.
A session at ISPOR Europe 2018 reported on the progress on its ISPOR Health Economics and Outcomes Research Competencies Framework™ initiative.
Three presentations to be given at the American Public Health Meeting Nov. 12-12 in San Diego.
A session at ISPOR Europe 2018 explored how patient engagement is transforming healthcare.
ISPOR, the professional society for health economics and outcomes research (HEOR), presented a number of honorees with its annual HEOR awards this morning at ISPOR Europe 2018.
A session at ISPOR Europe 2018 explored the issue of valuing a cure in healthcare.
The second plenary at ISPOR Europe 2018, “Pharmaceutical Pricing: The Many Faces of Fairness,” sought to define “fair” in the context of pharmaceutical pricing.
Nearly half of black teenagers surveyed in Allegheny County report losing a friend or family member to murder, a disproportionately stark statistic that is associated with suicide attempts and other negative childhood experiences.
New team-based care guided by a personalized risk score for heart failure patients reduced the mortality rate of high-risk heart failure patients by nearly 50 percent, according to new research from the Intermountain Medical Center Heart Institute in Salt Lake City.
ISPOR Europe 2018 session explored the evolving European Union policy landscape with panelists discussing if Europe is on the right path to improve outcomes research of medical devices.
ISPOR Europe 2018 session explored health technology assessment value-based pricing versus WHO fair pricing to assess which approach best delivers universal health coverage.
Hepatitis C drugs cure more than 90 percent of patients, but can cost more than $50,000 per patient. Findings from a new study could lead to big cost savings. In 50 percent of patients, the standard 12-week treatment regimen could be shortened to as little as six weeks without compromising efficacy.
A session, “Healthcare X.0: Digital Technologies and Creation of Value,” at ISPOR Europe 2018 explored how digital technologies are creating the next generation healthcare system in Europe and beyond.
ISPOR Europe 2018 session, “Will Machines Soon Make Health Economists Obsolete?” explored the impact of machine learning on health economics.
Donald S. Burke, M.D., dean of the University of Pittsburgh Graduate School of Public Health and Distinguished University Professor of Health Science and Policy, today will receive the prestigious John Snow Award from the American Public Health Association and the Royal Society for Public Health.
ISPOR Europe 2018 opened this morning with its first plenary, “Joint Assessment of Relative Effectiveness: ‘Trick or Treat’ for Decision Makers in the EU Member States,” a session on the impact of the European Commission’s Draft Regulation on health technology assessment.
The 2018 American Heart Association Scientific Sessions
Can your smart phone determine if you’re having the most serious – and deadly – form of heart attack? A new research study says it can – and may be a valuable tool to save lives.
Heart complications in patients diagnosed with bacterial pneumonia are more serious than in patients diagnosed with viral pneumonia, according to new research from the Intermountain Heart Institute at Intermountain Medical Center in Salt Lake City.
A new study presented at the American Heart Association Scientific Session conference has found that patients with atrial fibrillation (AF) also show signs of asymptomatic brain injury.
For patients who take medication to treat hypothyroidism, being treated with too much medication can lead to an increased risk of atrial fibrillation, a common heart rhythm disorder associated with stroke, a new study of more than 174,000 patients has found.
SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that patients treated with immune checkpoint inhibitors rarely develop severe liver toxicity, but the majority of those who do permanently stop this cancer treatment. None of the patients developed liver failure as a result of this treatment.
SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that people who inject drugs who are infected with the hepatitis C virus have high rates of hepatitis C treatment adherence (completion of their treatment), and sustained virologic response. Based on these findings, researchers conclude these patients should be included in HCV treatment programs.
SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by The American Association for the Study of Liver Diseases – found that universal screening of pregnant women at risk for hepatitis C virus (commonly called HCV) infection is a more efficient and cost-effective diagnostic approach than risk-based screening.
SAN FRANCISCO – Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that using normothermic machine perfusion to preserve steatotic livers leads to altered lipid structure and metabolism and may result in more successful transplantation of these organs.
SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that weight-loss surgery prior to liver transplantation is superior to medical weight loss approaches at achieving sustained weight loss, as well as significantly lowering risk of metabolic complications after transplant.
SAN FRANCISCO – Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that hospitalizations and death are increasing among Medicare recipients with hepatocellular carcinoma, mainly due to co-existing alcoholic liver disease, hepatitis C virus infection (commonly called HCV) and nonalcoholic fatty liver disease (commonly called NAFLD).
SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that African-American patients on waitlists for liver transplantation, despite severe disease and high scores for prioritization, persistently face significant disparities and delays in referral.
SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that rates of malignancy occurring outside of the liver were higher in adults with nonalcoholic fatty liver disease than among adults across most types of cancers.
SAN FRANCISCO – Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that more than half of pediatric liver transplant recipients are under-immunized at the time of their transplant and are at increased risk for vaccine-preventable infections.
SAN FRANCISCO – Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that taking a regular aspirin is associated with a dose-dependent reduction in the risk of hepatocellular carcinoma, one of the most common liver cancers. The cancer risk reduction is apparent after at least five years of aspirin use, the study showed.
SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that pre-emptive administration of pan-genotypic, direct-acting antiviral therapy prevents chronic hepatitis C virus infection in hepatitis C-negative cardiac transplant patients who receive donor hearts infected with the virus.
SAN FRANCISCO – Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found the combination of glecaprevir and pibrentasvir is highly effective and well tolerated in patients with chronic hepatitis C virus (commonly called HCV) genotype-1 infections who have prior treatment experience with sofosbuvir/NS5A inhibitor.
Faculty from BIDMC's CardioVascular Institute and colleagues will be presenting new advances and research at the 2018 American Heart Association (AHA) Scientific Sessions.
By eliminating one type of immune cell in the brain, researchers were able to erase any evidence of inflammation following traumatic brain injury, according to a new study from The Ohio State University.
Singing may provide benefits beyond improving respiratory and swallow control in people with Parkinson’s disease. New data revealed improvements in mood and motor symptoms, as well as reduced physiological indicators of stress.
The immune system might play an important role in the development of postpartum depression after a stressful pregnancy, new research suggests.
A widely used naloxone nasal spray (NNS) and naloxone injection (NIJ), otherwise known as Narcan® and Evzio®, which are administered to prevent opioid overdose deaths, were found to be chemically stable up for at least ten months and beyond one year of the expiration date, respectively.
Patient talks will inform scientists and clinicians on etiology and impact
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right